Study Shows CeraLyte Relieves Children's Seizures

Treatment Study of Jewish Genetic Disease, Published in Epilepsia, November 2004

Baltimore, MD (December 1, 2004)--A study of three children in the Mallow family of Florida, who suffer from Familial Dysautonomia (FD) -- a Jewish genetic disease with symptoms including seizures, developmental delays, lack of tears, feeding problems and a tendency to develop pneumonia from food aspiration in the lungs--showed favorable results when the children were treated with the rice-based oral rehydration solution (ORS) CeraLyte, produced by Maryland biotech company Cera Products of Columbia, MD.

The children drink three liters per day (each) of CeraLyte-90, which “induced freedom” from the seizures and normalization of EEG (a test to detect abnormalities in electrical activity in the brain) in all three patients. The study’s author, Dr. Juan G. Ochoa of the University of Florida, concluded the combination therapy of Topamax and CeraLyte may play a role in prevention and control of seizures due to Familial Dysautonomia.

One in 30 persons of Ashkenazi Jewish origin carries a genetic mutation for the FD gene, almost as high as the incidence of Tay Sachs Disease. FD is a disorder of the autonomic and sensory nervous systems, which prevents the body from regulating itself, along with inability to feel pain, temperature sensations, and trouble chewing, swallowing and digesting food. When FD children catch a cold or get upset, their systems are unable to regulate themselves. Their GI tracts shut down, causing blood sugar drops or electrolyte imbalance and seizures..

Cera Products Press Contact

Charlene Riikonen
410.309.1000 or charlene.riikonen@ceraproducts.us

Cera Products Inc.

Established in Maryland in 1993, Cera Products scientifically developed its high performance medical and sports rehydration products along with world health experts – including physicians at Johns Hopkins, the Mayo Clinic, Harvard University, University of Maryland, and Tufts University Schools of Medicine, the Food and Drug Administration, Centers for Disease Control – and with experts at leading food and pharmaceutical manufacturing companies. For more information, visit the Cera Products website at www.ceraproductsinc.com.

###